Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Flow Cytometry-Based Assessment of the Proportion of Monoclonal Plasma Cells in Synthetic Phase (S-phase) Is an Independent Marker of Adverse Prognosis in Patients with Newly Diagnosed Multiple Myeloma

Blood (2024) 144 (Supplement 1): 4704.

https://doi.org/10.1182/blood-2024-201052

Published: 2024

Journal Articles

A Comparative Study of Plasma Cell Detection By Peripheral Smear and Peripheral Blood Flow Cytometry

Arwa Bohra, Rafla Hassan, Saurabh Zanwar, Dragan Jevremovic, Horatiu Olteanu, Wilson I. Gonsalves, Gregory Otteson, Pedro Horna, S. Vincent Rajkumar, Shaji Kumar

Blood (2024) 144 (Supplement 1): 3319.

https://doi.org/10.1182/blood-2024-211626

Published: 2024

Journal Articles

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Chronic Lymphocytic Leukemia

April Chiu, Jansen N Seheult, Min Shi, Dragan Jevremovic, Matthew J Weybright, Michael M Timm, Gregory E Otteson, Horatiu Olteanu, Pedro Horna

Blood (2024) 144 (Supplement 1): 1858.

https://doi.org/10.1182/blood-2024-199901

Published: 2024

Journal Articles

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual B Lymphoblastic Leukemia

Jansen N Seheult, Matthew J Weybright, Min Shi, Dragan Jevremovic, April Chiu, Michael M Timm, Gregory E Otteson, Horatiu Olteanu, Pedro Horna

Blood (2024) 144 (Supplement 1): 4226.

https://doi.org/10.1182/blood-2024-199894

Published: 2024

Journal Articles

Presence of Circulating Tumor Cells on Peripheral Blood Flow Cytometry at Best Response Predicts Overall Survival in Multiple Myeloma

Arwa Bohra, Saurabh Zanwar, Dragan Jevremovic, Horatiu Olteanu, Wilson I. Gonsalves, Gregory Otteson, Pedro Horna, Vincent Rajkumar, Shaji Kumar

Blood (2024) 144 (Supplement 1): 3340.

https://doi.org/10.1182/blood-2024-212089

Published: 2024

Journal Articles

Machine Learning Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Acute Myeloid Leukemia

Jansen N Seheult, Min Shi, Horatiu Olteanu, Gregory E Otteson, Michael M Timm, Matthew J Weybright, Pedro Horna

Blood (2023) 142 (Supplement 1): 4339.

https://doi.org/10.1182/blood-2023-190275

Published: 2023

Journal Articles

Improved semiautomated detection of TRBC-restricted Sézary cells unveils a spectrum of clonal cluster immunophenotypes

Pedro Horna, Gregory Otteson, Min Shi, Jansen N. Seheult, Dragan Jevremovic, Horatiu Olteanu

Blood (2022) 140 (26): 2852–2856.

https://doi.org/10.1182/blood.2022017548

Published: 2022

Includes: Supplemental data

Journal Articles

Comparative Assessment of Surface CD19 and CD20 Expression on B-Cell Lymphomas from Clinical Biopsies: Implications for Targeted Therapies

Pedro Horna, MD, Grzegorz Nowakowski, MD, Jan Endell, Rainer Boxhammer

Blood (2019) 134 (Supplement_1): 5345.

https://doi.org/10.1182/blood-2019-129600

Published: 2019

Journal Articles

Single-Antibody Detection of T-Cell Receptor Beta Chain Monotypia Resolves Uncertainties in the Identification and Quantitation of Sézary Cells By Routine Flow Cytometry: Towards Accurate and Unequivocal Blood Staging of Cutaneous T-Cell Lymphomas

Pedro Horna, MD, Min Shi, MD PhD, Dragan Jevremovic, MD PhD, Horatiu Olteanu, MD PhD

Blood (2019) 134 (Supplement_1): 2848.

https://doi.org/10.1182/blood-2019-129477

Published: 2019

Journal Articles

Recurrent Chromosomal Abnormalities in Tumoral Lesions of Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Large-Scale Fluorescent in-Situ Hybridization Study on Tissue Biopsy Sections

Pedro Horna, MD, Kathryn E. Pearce, Rhett P. Ketterling, MD, Jess Peterson, MD

Blood (2019) 134 (Supplement_1): 4282.

https://doi.org/10.1182/blood-2019-129116

Published: 2019

Journal Articles

Clinical Correlates, Prognostic Impact and Survival Outcomes in Chronic Myelomonocytic Leukemia Patients with Myeloproliferative Neoplasm Associated-Driver Mutations

Prateek Pophali, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Pedro Horna, MD, Rhett P. Ketterling, Naseema Gangat, MBBS, Kebede H. Begna, MD, Abhishek A. Mangaonkar, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Mrinal M. Patnaik, MD MBBS

Blood (2018) 132 (Supplement 1): 3100.

https://doi.org/10.1182/blood-2018-99-117335

Published: 2018

Journal Articles

An Analysis of a Multidisciplinary Lymphoma Virtual Tumor Board with Regional and International Participation

Thomas M. Habermann, MD, Ruth A Lentz, R.N., John J Schmitz, MD, Alexander G von Bormann, BA, Jason Young, MD, Christopher H Hunt, MD, Grzegorz S. Nowakowski, MD, Kristen McCullough, PharmD, Pedro Horna, MD, Adam J Wood, MD, William R. Macon, MD, Paul J Kurtin, MD, Scott L Stafford, MD, Usha Sree Chamarthy, MD, Faraz Khan, MD, Stephen M. Ansell, MD PhD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 2247.

https://doi.org/10.1182/blood-2018-99-112887

Published: 2018

Journal Articles

Sézary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Outcomes

Christa Roe, RN, BS, OCN, Jennifer Rock-Klotz, BA, Elyce Turba, RN, MSN, OCN, Christopher Rodriguez Salamanca, PA, Janice Bennett, MS, ARNP-C, Farrah Farquharson, PA, Sem Bastien, MS, ARNP-C, Barbara Williams, RN, BS, OCN, Rebecca Levy, MS, ARNP-C, Yibo Li, BS, Michael Montejo, MD, Ernesto Ayala, MD, Pedro Horna, MD, Lewis F Glass, MD, Rami S. Komrokji, MD, Lubomir Sokol, MD PhD

Blood (2015) 126 (23): 1546.

https://doi.org/10.1182/blood.V126.23.1546.1546

Published: 2015

Journal Articles

Selective Inhibition of HDAC6 Decreases Viability of Cutaneous T-Cell Lymphoma and Improves Immune Recognition

Tessa Knox, MS, Maritza Lienlaf, MS, Patricio Perez-Villarroel, BS., Calvin Lee, MD, Eva Sahakian, PhD, John J. Powers, B.S., Fengdong Cheng, MD, Jorge Canales, MS, Danay Marante, MS, Ed Seto, PhD, Eduardo M. Sotomayor, MD, Alejandro Villagra, PhD, Pedro Horna, MD

Blood (2014) 124 (21): 5423.

https://doi.org/10.1182/blood.V124.21.5423.5423

Published: 2014

Journal Articles

A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor Panobinostat (LBH589) in Addition to Glucocorticoids in Patients with Acute Graft-Versus-Host Disease

Lia Perez, MD, Teresa Field, MD PhD, Marcie L Riches, MD MS, Hugo F Fernandez, MD, Frederick L Locke, MD, Brian C Betts, MD, Joseph Pidala, MD PhD, Erika Elmer, CCRP, Francisca Beato, BS, Maritza Lienlaf, MS, Pedro Horna, MD, Alejandro Villagra, PhD, Claudio Anasetti, MD

Blood (2014) 124 (21): 1167.

https://doi.org/10.1182/blood.V124.21.1167.1167

Published: 2014

Journal Articles

Histone Deacetylase 11 (HDAC11) As a Novel Transcriptional Regulator of C/EBP-β, in Immature Myeloid Cell to Myeloid Derived Suppressor Cell Transition

Jie Chen, MA, Eva Sahakian, PhD, John J. Powers, B.S., Maritza LienlafMoreno, BS, Limin Xing, PhD, Susan Deng, Allison Distler, Fengdong Cheng, MD, Alejandro Villagra, PhD, Pedro Horna, MD, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD PhD

Blood (2014) 124 (21): 225.

https://doi.org/10.1182/blood.V124.21.225.225

Published: 2014

Journal Articles

Concurrent Epstein Barr Virus Viremia and Hodgkin Lymphoma In Two Patients With Chronic Lymphocytic Leukemia

Samir Dalia, MD, Jason B. Brayer, MD, PhD, Julio C Chavez, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Pedro Horna, M.D., Hailing Zhang, MD, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD, PhD

Blood (2013) 122 (21): 5290.

https://doi.org/10.1182/blood.V122.21.5290.5290

Published: 2013

Journal Articles

A Novel Role For Histone Deacetylase 11 (HDAC11) As a Regulator Of Neutrophil Function and Differentiation In Normal and Malignant Hematopoesis

Eva Sahakian, Ph.D, John Powers, B.S., Jie Chen, M.A., Allison Distler, B.S., Jennifer Rock-Klotz, B.S., Susan Deng, B.S., Sheng Wei, MD, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, M.D. Ph.D., Pedro Horna, M.D.

Blood (2013) 122 (21): 2267.

https://doi.org/10.1182/blood.V122.21.2267.2267

Published: 2013

Journal Articles

Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma

Blood (2013) 122 (21): 842.

https://doi.org/10.1182/blood.V122.21.842.842

Published: 2013

Journal Articles

A Close Association of History of Autoimmunity with Chronic Myelomonocytic Leukemia (CMML) in Contrast to Chronic Myelogenous Leukemia (CML)

Deniz Peker, MD, Eric Padron, MD, Pedro Horna, MD, John M. Bennett, MD, Xiaohui Zhang, MD, P.K. Epling-Burnette, PharmD, PhD, Jeffrey E Lancet, MD, Javier Pinilla, Lynn Moscinski, MD, Alan F. List, MD, Rami S. Komrokji, MD, Ling Zhang, MD

Blood (2012) 120 (21): 1712.

https://doi.org/10.1182/blood.V120.21.1712.1712

Published: 2012

NARROW

Flow Cytometry-Based Assessment of the Proportion of Monoclonal Plasma Cells in Synthetic Phase (S-phase) Is an Independent Marker of Adverse Prognosis in Patients with Newly Diagnosed Multiple Myeloma

A Comparative Study of Plasma Cell Detection By Peripheral Smear and Peripheral Blood Flow Cytometry

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Chronic Lymphocytic Leukemia

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual B Lymphoblastic Leukemia

Presence of Circulating Tumor Cells on Peripheral Blood Flow Cytometry at Best Response Predicts Overall Survival in Multiple Myeloma

Machine Learning Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Acute Myeloid Leukemia

Improved semiautomated detection of TRBC-restricted Sézary cells unveils a spectrum of clonal cluster immunophenotypes

Comparative Assessment of Surface CD19 and CD20 Expression on B-Cell Lymphomas from Clinical Biopsies: Implications for Targeted Therapies

Single-Antibody Detection of T-Cell Receptor Beta Chain Monotypia Resolves Uncertainties in the Identification and Quantitation of Sézary Cells By Routine Flow Cytometry: Towards Accurate and Unequivocal Blood Staging of Cutaneous T-Cell Lymphomas

Recurrent Chromosomal Abnormalities in Tumoral Lesions of Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Large-Scale Fluorescent in-Situ Hybridization Study on Tissue Biopsy Sections

Clinical Correlates, Prognostic Impact and Survival Outcomes in Chronic Myelomonocytic Leukemia Patients with Myeloproliferative Neoplasm Associated-Driver Mutations

An Analysis of a Multidisciplinary Lymphoma Virtual Tumor Board with Regional and International Participation

Sézary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Outcomes

Selective Inhibition of HDAC6 Decreases Viability of Cutaneous T-Cell Lymphoma and Improves Immune Recognition

A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor Panobinostat (LBH589) in Addition to Glucocorticoids in Patients with Acute Graft-Versus-Host Disease

Histone Deacetylase 11 (HDAC11) As a Novel Transcriptional Regulator of C/EBP-β, in Immature Myeloid Cell to Myeloid Derived Suppressor Cell Transition

Concurrent Epstein Barr Virus Viremia and Hodgkin Lymphoma In Two Patients With Chronic Lymphocytic Leukemia

A Novel Role For Histone Deacetylase 11 (HDAC11) As a Regulator Of Neutrophil Function and Differentiation In Normal and Malignant Hematopoesis

Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma

A Close Association of History of Autoimmunity with Chronic Myelomonocytic Leukemia (CMML) in Contrast to Chronic Myelogenous Leukemia (CML)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only